Paid Clinical Trials in Hickory, NC
As of August 2026, 21 paid clinical trials are recruiting in Hickory, North Carolina. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Hickory offers studies at sites including Graystone Eye for conditions such as Graves' Disease, Macular Degeneration, Major Depressive Disorder, AGA. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by drug in Hickory
Filter results
19 clinical trials
CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
Characterization And Clinical Outcomes of AA Patients Treated With Ritlecitinib
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid Tumors
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint In
ATHNdataset Registry
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Safety and Efficacy of VDPHL01 in Females With Androgenetic Alopecia (AGA)
Study of ALTO-300 in MDD
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
Top Research Study Locations in Hickory
Researchers run research studies in Hickory, NC at 12 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Graystone Eye | Macular Degeneration, Age-Related Macular Degeneration, Age-related Macular Degeneration (AMD) | 4 |
| Accellacare - Hickory | Clostridioides Difficile Associated Disease | 1 |
| Accellacare of Hickory | Psoriatic Arthritis | 1 |
| Advanced Respiratory and Sleep Medicine - Hickory | Chronic Obstructive Pulmonary Disease | 1 |
| Adverum Clinical | Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD | 1 |
| American Thrombosis and Hemostasis Network | Bleeding Disorder, Blood Disorder, Glanzmann Thrombasthenia | 1 |
| Carolina Oncology Specialists | NSCLC Stage IV | 1 |
| Exelixis Clinical | Advanced Solid Tumor, Immune Sensitive Tumor, Metastatic Solid Tumor | 1 |
| Graystone Eye - Hickory Office | DME, Diabetic Macular Edema, Diabetic Macular Edema (DME) | 1 |
| Hickory Dermatology Research Center | Alopecia Areata | 1 |
| OnSite Clinical Solutions, LLC - Hickory | Migraine | 1 |
| Viewmont Surgery Center | Lumbar Spinal Stenosis | 1 |
Active & Upcoming Studies in Hickory (2026)
Recruiting trials in Hickory grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Eye & vision (6 active studies)
- A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003) · Phase 2, Phase 3 · EyeBiotech Ltd.
- Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS) · Phase 3 · Adverum Biotechnologies, Inc.
Cancer & tumors (1 active study)
Neurology & pain (1 active study)
Cardiovascular (1 active study)
Common conditions studied in Hickory
- Graves' Disease (2 active studies)
- Macular Degeneration (2 active studies)
- Major Depressive Disorder (2 active studies)
- AGA (1 active study)
- Advanced Solid Tumor (1 active study)
- Age-Related Macular Degeneration (1 active study)
Leading research sponsors in Hickory
- Immunovant Sciences GmbH
- Pfizer
- AbbVie
- Adverum Biotechnologies, Inc.
- Alto Neuroscience
Frequently asked questions
How many paid clinical trials are currently recruiting in Hickory?
There are approximately 21 recruiting clinical trials in Hickory, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Hickory pay participants?
Most recruiting trials in Hickory compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Hickory?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Hickory?
The most common conditions under active study in Hickory include Graves' Disease (2), Macular Degeneration (2), Major Depressive Disorder (2), AGA (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Hickory?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Hickory on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Hickory?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Hickory?
Recruiting research sites in Hickory include Graystone Eye, Accellacare - Hickory, Accellacare of Hickory, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Hickory right now?
The largest active categories in Hickory are Eye & vision (6), Cancer & tumors (1), Neurology & pain (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.